A study to evaluate the efficacy of Ayurvedic medicines Kaisora Guggulu and Madhusnuhi rasayan in the treatment of Gout, a condition associated with painful joints and raised blood levels of uric acid.

THERAPEUTIC EVALUATION OF KAISORA GUGGULU AND MADHUSNUHI RASAYANA IN VATARAKTA (GOUT)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/08/004917

Enrollment

Registered

2014-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient suffering from joint pain with serum uric acid more than 7mg/dl

Interventions

Intervention1: THERAPEUTIC EVALUATION OF KAISORA GUGGULU AND MADHUSNUHI RASAYANA IN VATARAKTA (GOUT): THERAPEUTIC EVALUATION OF KAISORA GUGGULU AND MADHUSNUHI RASAYANA IN VATARAKTA (GOUT) Intervention

Eligibility

Inclusion criteria

Inclusion criteria: FULFILLING THE DIAGNOSTIC CRITERIA AS RECOMMENDED BY THE AMERICAN COLLEGE OF RHEUMATOLOGY (1977)

Exclusion criteria

Exclusion criteria: PATIENTS WITH TRAUMA, FRACTURE, HEART DISEASE, MALIGNANCY, HYPO-HYPER THYROIDISM, DRUG ABUSERS, PREGNANT, LACTATING WOMEN AND ANY OTHER CONDITION WHICH THE PRINCIPAL INVESTIGATOR THINKS MAY JEOPARDIZE THE STUDY.

Design outcomes

Primary

Measure	Time frame
MEAN PERCENTAGE DECREASE IN SERUM URIC ACID LEVEL FROM THE BASELINE TO THE END OF THE STUDY.Timepoint: ï?? Total Study Period : 24 months Pre-trial preparatory period: ï?¶ Recruitment of staff/Literature survey/ Screening of patients/Procurement of medicine etc. : 3 months ï?¶ Washout Period (if required) : 02 weeks ï?§ Recruitment patients/follow ups/ data recording : 18 months ï?§ Data analysis/report preparation/ submission : 03 months ï?§ Treatment Period : 12 weeks ï?§ Follow-Up Period : 02 weeks	—

Measure

Time frame

MEAN PERCENTAGE DECREASE IN SERUM URIC ACID LEVEL FROM THE BASELINE TO THE END OF THE STUDY.Timepoint: ï?? Total Study Period : 24 months Pre-trial preparatory period: ï?¶ Recruitment of staff/Literature survey/ Screening of patients/Procurement of medicine etc. : 3 months ï?¶ Washout Period (if required) : 02 weeks ï?§ Recruitment patients/follow ups/ data recording : 18 months ï?§ Data analysis/report preparation/ submission : 03 months ï?§ Treatment Period : 12 weeks ï?§ Follow-Up Period : 02 weeks

—

Secondary

Measure	Time frame
IMPROVEMENT IN SF-36 HEALTH SURVEY SCORE, PATIENTS GLOBAL ASSESSMENT PAIN VISUAL ANALOGUE SCALE.Timepoint: ï?? Total Study Period : 24 months Pre-trial preparatory period: ï?¶ Recruitment of staff/Literature survey/ Screening of patients/Procurement of medicine etc. : 3 months ï?¶ Washout Period (if required) : 02 weeks ï?§ Recruitment patients/follow ups/ data recording : 18 months ï?§ Data analysis/report preparation/ submission : 03 months ï?§ Treatment Period : 12 weeks ï?§ Follow-Up Period : 02 weeks	—

Measure

Time frame

IMPROVEMENT IN SF-36 HEALTH SURVEY SCORE, PATIENTS GLOBAL ASSESSMENT PAIN VISUAL ANALOGUE SCALE.Timepoint: ï?? Total Study Period : 24 months Pre-trial preparatory period: ï?¶ Recruitment of staff/Literature survey/ Screening of patients/Procurement of medicine etc. : 3 months ï?¶ Washout Period (if required) : 02 weeks ï?§ Recruitment patients/follow ups/ data recording : 18 months ï?§ Data analysis/report preparation/ submission : 03 months ï?§ Treatment Period : 12 weeks ï?§ Follow-Up Period : 02 weeks

—

Countries

India

Contacts

Public ContactPURNENDU PANDA

NATIONAL RESEARCH INSTITUTE OF AYURVEDA DRUG DEVELOPMENT

pandapurnendu02@yahoo.com9777852889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026